Castelein Caley (CIK 1355758) reported 4 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-18). Recent activity: Buy WHWK (255,102 shares), Sell TRML (515,997 shares), Sell TRML (431,939 shares), Sell TRML (522 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | Whitehawk Therapeutics, Inc. (WHWK) | Director | Buy | 255,102 | $1,000,000 |
| 2025-10-28 | Tourmaline Bio, Inc. (TRML) | Director | Sell | 515,997 | $0 |
| 2025-10-28 | Tourmaline Bio, Inc. (TRML) | Director | Sell | 431,939 | $0 |
| 2025-10-17 | Tourmaline Bio, Inc. (TRML) | Director | Sell | 522 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-05-18